Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × glembatumumab vedotin × Breast × Clear all

Status

Withdrawn 2 Completed 2 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Metastatic gpNMB Expressing Triple Negative Breast Cancer 1

Interventions

veliparib 2 tucatinib 1 pegilodecakin 1 palbociclib 1 leronlimab 1 iniparib 1 glembatumumab vedotin 1 Vinorelbine 1 Letrozole 1 Everolimus 1 Cisplatin 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

Celldex Therapeutics

No longer available

Metastatic gpNMB Expressing Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡